Rajiv Gandhi Cancer Institute gets cutting edge technology
29 Nov 2012 11:59 PM GMT
Rajiv Gandhi Cancer Institute & Research Centre (RGCI and RC) in Delhi has become the first exclusive cancer care provider in North India to install the next generation of breast imaging.
Digital Breast Tomosynthesis is a high-end technology that takes multiple breast images within seconds to aid early detection of cancer, especially in dense breasts. A computer then produces 3D images of the breast tissue in one millimeter layers.
According to Arvind K Chaturvedi, director of radiology, RGCI and RC, ‘the Digital Breast Tomosynthesis is a step forward in breast cancer detection, which can help spot cancers in dense breasts also as the breast is virtually sliced into multiple images in this imaging procedure. The X-ray arm sweeps in an arc over the breast to capture 30-40 images of each breast. The number of biopsies is drastically reduced as compared to after a mammography and the images are acquired in a single compression.’
The conventional monogram technology delivers a 2-dimensional image of the breast which is then followed by continual investigation and at times unnecessary biopsies. Especially in the case of breasts with higher density which are composed of pockets of dense tissues surrounded by fat, overlapping of tissues makes it critical to judge the tiny spots called micro calcifications, and other subtle signs of early cancer.
‘In Indian metro cities, breast cancer appears to be the most widespread cancer among women even leaving behind cervical cancer. Digital Breast Tomosynthesis is a technology that can turn around this situation as it reduces the investigation time and therefore treatmentcan be started early,’ added Chaturvedi.
The rising incidence of breast cancer diagnosis in young women is a cause of concern. Late pregnancies, reduced breast feeding and changed lifestyle are some of the prominent factors that make women more prone to breast cancer.
Rajiv Gandhi Cancer Institute & Research Centre (RGCI&RC) is one of India’s premier cancer care institutions comprising 241 beds. Founded on the vision of preventing and treating cancer via affordable oncology care of global standards, over the years RGCI&RC has proved its credentials as a Centre of Excellence in cancer care by attendingto about 125,000 patients from India and neighbouring nations such as Nepal, Bangladesh, Sri Lanka and others.
Digital Breast Tomosynthesis is a high-end technology that takes multiple breast images within seconds to aid early detection of cancer, especially in dense breasts. A computer then produces 3D images of the breast tissue in one millimeter layers.
According to Arvind K Chaturvedi, director of radiology, RGCI and RC, ‘the Digital Breast Tomosynthesis is a step forward in breast cancer detection, which can help spot cancers in dense breasts also as the breast is virtually sliced into multiple images in this imaging procedure. The X-ray arm sweeps in an arc over the breast to capture 30-40 images of each breast. The number of biopsies is drastically reduced as compared to after a mammography and the images are acquired in a single compression.’
The conventional monogram technology delivers a 2-dimensional image of the breast which is then followed by continual investigation and at times unnecessary biopsies. Especially in the case of breasts with higher density which are composed of pockets of dense tissues surrounded by fat, overlapping of tissues makes it critical to judge the tiny spots called micro calcifications, and other subtle signs of early cancer.
‘In Indian metro cities, breast cancer appears to be the most widespread cancer among women even leaving behind cervical cancer. Digital Breast Tomosynthesis is a technology that can turn around this situation as it reduces the investigation time and therefore treatmentcan be started early,’ added Chaturvedi.
The rising incidence of breast cancer diagnosis in young women is a cause of concern. Late pregnancies, reduced breast feeding and changed lifestyle are some of the prominent factors that make women more prone to breast cancer.
Rajiv Gandhi Cancer Institute & Research Centre (RGCI&RC) is one of India’s premier cancer care institutions comprising 241 beds. Founded on the vision of preventing and treating cancer via affordable oncology care of global standards, over the years RGCI&RC has proved its credentials as a Centre of Excellence in cancer care by attendingto about 125,000 patients from India and neighbouring nations such as Nepal, Bangladesh, Sri Lanka and others.
Next Story
